I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 16 studies | 25% ± 7% | |
| ciliated cell | 13 studies | 31% ± 12% | |
| astrocyte | 11 studies | 30% ± 13% | |
| fibroblast | 10 studies | 22% ± 6% | |
| glutamatergic neuron | 9 studies | 41% ± 24% | |
| endothelial cell of lymphatic vessel | 8 studies | 27% ± 8% | |
| GABAergic neuron | 8 studies | 44% ± 20% | |
| adipocyte | 8 studies | 22% ± 6% | |
| oligodendrocyte precursor cell | 7 studies | 35% ± 15% | |
| mast cell | 6 studies | 24% ± 5% | |
| retinal cone cell | 6 studies | 34% ± 8% | |
| retinal rod cell | 6 studies | 19% ± 4% | |
| Mueller cell | 6 studies | 26% ± 11% | |
| oligodendrocyte | 6 studies | 27% ± 9% | |
| macrophage | 6 studies | 26% ± 6% | |
| pericyte | 6 studies | 21% ± 4% | |
| myeloid cell | 5 studies | 23% ± 5% | |
| epithelial cell | 5 studies | 35% ± 8% | |
| cardiac muscle cell | 5 studies | 40% ± 10% | |
| natural killer cell | 5 studies | 19% ± 4% | |
| microglial cell | 5 studies | 25% ± 7% | |
| interneuron | 5 studies | 47% ± 24% | |
| retinal bipolar neuron | 4 studies | 17% ± 1% | |
| amacrine cell | 4 studies | 19% ± 4% | |
| smooth muscle cell | 4 studies | 23% ± 6% | |
| lymphocyte | 4 studies | 22% ± 2% | |
| connective tissue cell | 4 studies | 21% ± 3% | |
| monocyte | 4 studies | 21% ± 3% | |
| T cell | 4 studies | 18% ± 2% | |
| neuron | 4 studies | 32% ± 12% | |
| B cell | 3 studies | 20% ± 3% | |
| retina horizontal cell | 3 studies | 21% ± 2% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 19% ± 2% | |
| GABAergic amacrine cell | 3 studies | 19% ± 3% | |
| glycinergic amacrine cell | 3 studies | 21% ± 2% | |
| dendritic cell | 3 studies | 19% ± 1% | |
| ependymal cell | 3 studies | 31% ± 9% | |
| renal alpha-intercalated cell | 3 studies | 50% ± 14% |
